Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.33 |
| ▸ | TET3 | O43151 | 1/20 | 0.33 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopentane SCHEMBL17923114 | 0.92 | SLC1A1 (0.33) | SLC1A1OR51E2TET2TET3TET1 | |
| Cyclohexane SCHEMBL2468697 | 0.92 | SLC1A1 (0.33) | SLC1A1OR51E2TET2TET3TET1 | |
| SCHEMBL261773 | 0.92 | SLC1A1 (0.33) | SLC1A1OR51E2TET2TET3TET1 | |
| SCHEMBL4904183 | 0.85 | SLC1A1 (0.37) | SLC1A1 | |
| SCHEMBL10582349 | 0.85 | SLC1A1 (0.40) | SLC1A1TGFBR1 | |
| Pentadecane SCHEMBL15015716 | 0.84 | GPR84 (0.41) | OR51E2LMNA | |
| SCHEMBL3485361 | 0.82 | — | — | |
| SCHEMBL15514786 | 0.82 | — | — | |
| SCHEMBL712461 | 0.81 | CAMK2A (0.32) | SLC1A1 | |
| SCHEMBL2996538 | 0.78 | TET2 (0.31) | TET2TET3TET1GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1442895-B1 | A method for preparation of a lithographic printing plate and a lithographic printing plate produced by said method | TECHNOVA IMAGING SYSTEMS P LTD (IN) | 2008-05-14 | — | — | EP | claimed |
| EP-1432746-B1 | DEODORANTS AND ANTI-PERSPIRANTS | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2007-02-07 | — | — | EP | claimed |
| WO-2024116890-A1 | POLARIZING PLATE AND DISPLAY DEVICE USING SAME | 株式会社トッパンＴＯＭＯＥＧＡＷＡオプティカルフィルム | 2024-06-06 | — | — | WO | disclosed |
| WO-2024075658-A1 | POLARIZING PLATE AND DISPLAY DEVICE USING SAME | 株式会社トッパンＴＯＭＯＥＧＡＷＡオプティカルフィルム | 2024-04-11 | — | — | WO | disclosed |
| CN-114940864-B | Kindergarten wall based on novel erasable coating | 南通市建筑设计研究院有限公司 | 2023-08-29 | — | — | CN | disclosed |
| EP-2960230-B1 | RADICAL CURABLE MATERIAL | AUTONETWORKS TECHNOLOGIES LTD (JP) | 2020-05-06 | — | — | EP | disclosed |
| EP-2825595-A1 | THERMOSETTING RESIN COMPOSITIONS | DSM IP Assets B.V. (NL) | 2015-01-21 | — | — | EP | disclosed |
| WO-2013135625-A1 | THERMOSETTING RESIN COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2013-09-19 | — | — | WO | disclosed |
| US-20120201858-A1 | Multiple-arm peptide compounds, methods of manufacture and use in therapy | INCUBE LABS, LLC | 2012-08-09 | — | — | US | disclosed |
| EP-1667704-A1 | MULTIPLE-ARM PEPTIDE COMPOUNDS, METHODS OF MANUFACTURE AND USE IN THERAPY | Imran, Mir A. (US) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005027957-A1 | MULTIPLE-ARM PEPTIDE COMPOUNDS, METHODS OF MANUFACTURE AND USE IN THERAPY | IMRAN MIR A (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20050063937-A1 | Multiple-arm peptide compounds, methods of manufacture and use in therapy | INCUBE LABS, LLC | 2005-03-24 | — | — | US | disclosed |
| US-4653854-A | CROSSLINKED BY POLYISOCYANATE | SEIBU POLYMER KASEI KABUSHIKI KAISHA (JP) | 1987-03-31 | — | — | US | disclosed |
| US-4650743-A | PHOTOPOLYMERIZED HYDROZYALKYL ACRYLATE AND OLIGOMER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-03-17 | — | — | US | disclosed |
| EP-0210638-A2 | Optical coating composition | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120201858-A1 | Multiple-arm peptide compounds, methods of manufacture and use in therapy | ECPAS, FN1, ILK | SLC1A1 4293/4885OR51E2 3121/4885TET2 2701/4885 |
| US-20050063937-A1 | Multiple-arm peptide compounds, methods of manufacture and use in therapy | ECPAS, FN1, ILK | SLC1A1 4323/4885OR51E2 3162/4885TET2 2578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.